Literature DB >> 20836304

A comparative study of conjunctival autograft and minimally invasive pterygium surgery in primary pterygia.

N Bazzazi1, A Ramezani, M A S Rabiee.   

Abstract

This study aimed at comparing the results of the Conjunctival Autograft Technique (CAG) and Minimally Invasive Pterygium Surgery (MIPS) in primary pterygium excisions. This was a prospective randomized clinical study performed during a one-year period (2009-2010). One hundred and twenty two patients with primary pterygium were randomized in 2 groups: group A (CAG) including 36 patients and group B (MIPS) including 86 patients. The two groups were compared considering the recurrence rate and probable complications of the procedures. Recurrences were detected in 4 patients (11.1%) in group A and 5 patients (5.8%) in group B with no significant difference in this regard (p = 0.447). No major complications occurred during the follow-up period. This study showed that acceptable recurrence- free rates could be achieved (albeit nonsignificant) using MIPS technique in patients with primary pterygium and can be considered as a good alternative in the surgical management of pterygia because of its simplicity and low surgical time.

Entities:  

Mesh:

Year:  2010        PMID: 20836304     DOI: 10.3923/pjbs.2010.409.412

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN: 1028-8880


  3 in total

Review 1.  Mitomycin C in pterygium treatment.

Authors:  Thiago Gonçalves Dos Santos Martins; Ana Luiza Fontes de Azevedo Costa; Milton Ruiz Alves; Roger Chammas; Paulo Schor
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

2.  Recurrence rate with use of intraoperative Mitomycin C versus Conjunctival Autograft following pterygium excision.

Authors:  Quratulain Paracha; Mohammad Ayoob; Zafar Dawood; Sajid Ali Mirza
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

3.  Optimal size of pterygium excision for limbal conjunctival autograft using fibrin glue in primary pterygia.

Authors:  Ho Sik Hwang; Kyong Jin Cho; Gabriel Rand; Roy S Chuck; Ji Won Kwon
Journal:  BMC Ophthalmol       Date:  2018-06-07       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.